MetaADEDB 2.0 @ LMMD
Citalopram
(WSEQXVZVJXJVFP-FQEVSTJZSA-N)
Structure
SMILES
N#Cc1ccc2c(c1)CO[C@@]2(CCCN(C)C)c1ccc(cc1)F
Type(s)
Approved; Investigational
ATC code(s)
N06AB10
Molecular Formula:
C20H21FN2O
Molecular Weight:
324.392
Log P:
3.8130
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
0
TPSA:
36.26
CAS Number(s):
128196-01-0
Synonym(s)
1.
Citalopram
2.
Celexa
3.
Citalopram Hydrobromide
4.
Cytalopram
5.
Escitalopram
6.
Escitalopram Oxalate
7.
Lexapro
8.
Lu-10-171
9.
Seropram
10.
Lu10171
External Link(s)
MeSHD015283
PubChem Compound146570
BindingDB50302225
ChEBI36791
CHEMBLCHEMBL1508
DrugBankDB01175
DrugCentral1053
IUPHAR/BPS Guide to PHARMACOLOGY7177
KEGGdr:D07913
Therapeutic Target DatabaseD08RBC
ZINC3800706
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product substitution issueFAERS: 317
Canada Vigilance: 31
Canada Vigilance
US FAERS
2AnxietyFAERS: 254
Canada Vigilance: 24
Canada Vigilance
US FAERS
3Drug ineffectiveFAERS: 196
Canada Vigilance: 54
Canada Vigilance
US FAERS
4NauseaFAERS: 170
Canada Vigilance: 21
Canada Vigilance
US FAERS
5HeadacheFAERS: 142
Canada Vigilance: 20
Canada Vigilance
US FAERS
6DizzinessFAERS: 134
Canada Vigilance: 15
Canada Vigilance
US FAERS
7FatigueFAERS: 104
Canada Vigilance: 7
Canada Vigilance
US FAERS
8TremorFAERS: 98
Canada Vigilance: 8
Canada Vigilance
US FAERS
9Feeling abnormalFAERS: 80
Canada Vigilance: 6
Canada Vigilance
US FAERS
10VomitingFAERS: 57
Canada Vigilance: 8
Canada Vigilance
US FAERS
11AgitationFAERS: 56
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Drug withdrawal syndromeFAERS: 56
Canada Vigilance: 2
Canada Vigilance
US FAERS
13MalaiseFAERS: 52
Canada Vigilance: 3
Canada Vigilance
US FAERS
14SomnolenceFAERS: 50
Canada Vigilance: 3
Canada Vigilance
US FAERS
15PalpitationsFAERS: 48
Canada Vigilance: 2
Canada Vigilance
US FAERS
16AstheniaFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
17PregnancyFAERS: 40US FAERS
18OverdoseFAERS: 37US FAERS
19Drug exposure during pregnancyFAERS: 36US FAERS
20CryingFAERS: 35US FAERS
21Depressed moodFAERS: 35
Canada Vigilance: 4
Canada Vigilance
US FAERS
22Product quality issueFAERS: 35US FAERS
23RestlessnessFAERS: 35
Canada Vigilance: 2
Canada Vigilance
US FAERS
24Completed SuicideFAERS: 34US FAERS
25Sexual DysfunctionFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Drug abuseFAERS: 28US FAERS
27Weight decreasedFAERS: 28US FAERS
28Angle Closure GlaucomaFAERS: 26US FAERS
29Memory impairmentFAERS: 26US FAERS
30Suicide attemptFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
31HypersensitivityFAERS: 24US FAERS
32TinnitusFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
33Urinary RetentionFAERS: 23US FAERS
34VertigoFAERS: 23
Canada Vigilance: 3
Canada Vigilance
US FAERS
35AngerFAERS: 22US FAERS
36AlopeciaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Serotonin SyndromeFAERS: 21US FAERS
38Intentional self-injuryFAERS: 19US FAERS
39PruritusFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
40Abdominal PainFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
41ArthralgiaFAERS: 18US FAERS
42ConstipationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Abdominal discomfortFAERS: 17
Canada Vigilance: 5
Canada Vigilance
US FAERS
44ChillsFAERS: 17US FAERS
45MetrorrhagiaFAERS: 16US FAERS
46Unevaluable eventFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
47Chest discomfortFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Disease recurrenceFAERS: 15US FAERS
49Impaired work abilityFAERS: 15US FAERS
50Activities of daily living impairedFAERS: 14US FAERS
51Chest PainFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
52Erectile dysfunctionFAERS: 14US FAERS
53NervousnessFAERS: 14
Canada Vigilance: 6
Canada Vigilance
US FAERS
54ParanoiaFAERS: 14US FAERS
55Toxicity to various agentsFAERS: 14US FAERS
56Visual ImpairmentFAERS: 14US FAERS
57AmnesiaFAERS: 13US FAERS
58BradycardiaFAERS: 13US FAERS
59Depressed Level of ConsciousnessFAERS: 13US FAERS
60Emotional disorderFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
61HypotensionFAERS: 13US FAERS
62Medication ErrorFAERS: 13US FAERS
63Alcohol abuseFAERS: 12US FAERS
64BruxismFAERS: 12US FAERS
65EpilepsyFAERS: 12US FAERS
66Loss of personal independence in daily activitiesFAERS: 12US FAERS
67MyalgiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
68PainFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
69RhabdomyolysisFAERS: 12US FAERS
70StressFAERS: 12US FAERS
71TalipesFAERS: 12US FAERS
72Breast CystFAERS: 11US FAERS
73DisorientationFAERS: 11US FAERS
74HypersomniaFAERS: 11US FAERS
75SyncopeFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
76TachycardiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
77UrticariaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
78Burning sensationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
79Negative thoughtsFAERS: 10US FAERS
80Night sweatsFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
81Product use issueFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
82ApathyFAERS: 9US FAERS
83Euphoric moodFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
84Exposure during breast feedingFAERS: 9US FAERS
85Feeling ColdFAERS: 9US FAERS
86Musculoskeletal stiffnessFAERS: 9US FAERS
87Neck PainFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
88Poor quality sleepFAERS: 9US FAERS
89PresyncopeFAERS: 9US FAERS
90SoporFAERS: 9US FAERS
91Bone painFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
92Emotional povertyFAERS: 8US FAERS
93EpistaxisFAERS: 8US FAERS
94Incorrect dose administeredFAERS: 8US FAERS
95LethargyFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Mood swingsFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Muscle RigidityFAERS: 8US FAERS
98MydriasisFAERS: 8
Canada Vigilance: 3
Canada Vigilance
US FAERS
99Prescribed overdoseFAERS: 8US FAERS
100jaundiceFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
101Cytolytic hepatitisFAERS: 7US FAERS
102Diabetes MellitusFAERS: 7US FAERS
103DiscomfortFAERS: 7US FAERS
104DissociationFAERS: 7US FAERS
105Emotional distressFAERS: 7US FAERS
106FlatulenceFAERS: 7US FAERS
107Mental impairmentFAERS: 7US FAERS
108No adverse eventFAERS: 7US FAERS
109Ocular HypertensionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
110PriapismFAERS: 7US FAERS
111SomnambulismFAERS: 7US FAERS
112TachyphreniaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
113Vulvovaginal discomfortFAERS: 7US FAERS
114Adverse eventFAERS: 6US FAERS
115AsphyxiaFAERS: 6US FAERS
116Atrial FibrillationFAERS: 6US FAERS
117BlepharospasmFAERS: 6US FAERS
118Cold sweatFAERS: 6US FAERS
119DemyelinationFAERS: 6US FAERS
120Disturbance in sexual arousalFAERS: 6US FAERS
121Drug dispensing errorFAERS: 6US FAERS
122Drug dose omissionFAERS: 6US FAERS
123DysarthriaFAERS: 6US FAERS
124General physical health deteriorationFAERS: 6US FAERS
125Initial insomniaFAERS: 6US FAERS
126Musculoskeletal PainFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
127MyoclonusFAERS: 6US FAERS
128Optic NeuritisFAERS: 6US FAERS
129PhotophobiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Pre-EclampsiaFAERS: 6US FAERS
131Sudden deathFAERS: 6US FAERS
132Tongue bitingFAERS: 6US FAERS
133YawningFAERS: 6US FAERS
134treatment failureFAERS: 6US FAERS
135AnorexiaFAERS: 5US FAERS
136AphasiaFAERS: 5US FAERS
137Back PainFAERS: 5US FAERS
138Blood creatine phosphokinase increasedFAERS: 5US FAERS
139Blood prolactin increasedFAERS: 5US FAERS
140Blood sodium decreasedFAERS: 5US FAERS
141BradyphreniaFAERS: 5US FAERS
142Breast hyperplasiaFAERS: 5US FAERS
143Cardiac ArrestFAERS: 5US FAERS
144Coronary Artery DiseaseFAERS: 5US FAERS
145Drug DependenceFAERS: 5US FAERS
146DysgeusiaFAERS: 5US FAERS
147DyspepsiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
148ErythemaFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
149Feeling jitteryFAERS: 5
Canada Vigilance: 5
Canada Vigilance
US FAERS
150Feelings of worthlessnessFAERS: 5US FAERS
151Gastric ulcerFAERS: 5US FAERS
152Gastrointestinal PainFAERS: 5US FAERS
153HyperreflexiaFAERS: 5US FAERS
154Impaired driving abilityFAERS: 5US FAERS
155Impaired gastric emptyingFAERS: 5US FAERS
156Inappropriate affectFAERS: 5US FAERS
157NeutropeniaFAERS: 5US FAERS
158Personality ChangeFAERS: 5US FAERS
159Quality of life decreasedFAERS: 5US FAERS
160RetchingFAERS: 5US FAERS
161Sinus bradycardiaFAERS: 5US FAERS
162Sudden Cardiac DeathFAERS: 5US FAERS
163Therapy cessationFAERS: 5US FAERS
164Ventricular FibrillationFAERS: 5US FAERS
165nervous system disorderFAERS: 5US FAERS
166Acute myocardial infarctionFAERS: 4US FAERS
167AgeusiaFAERS: 4US FAERS
168AkathisiaFAERS: 4US FAERS
169Alcohol interactionFAERS: 4US FAERS
170BedriddenFAERS: 4US FAERS
171Blood glucose decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Cerebrovascular accidentFAERS: 4US FAERS
173CholelithiasisFAERS: 4US FAERS
174Delusional disorder, erotomanic typeFAERS: 4US FAERS
175Drug administered to patient of inappropriate ageFAERS: 4US FAERS
176Drug prescribing errorFAERS: 4US FAERS
177DyscheziaFAERS: 4US FAERS
178DysuriaFAERS: 4US FAERS
179EcchymosisFAERS: 4US FAERS
180Economic problemFAERS: 4US FAERS
181Electrocardiogram abnormalFAERS: 4US FAERS
182EndometriosisFAERS: 4US FAERS
183GlaucomaFAERS: 4US FAERS
184HyperacusisFAERS: 4US FAERS
185Intentional product misuseFAERS: 4US FAERS
186Joint stiffnessFAERS: 4US FAERS
187KleptomaniaFAERS: 4US FAERS
188Libido disorderFAERS: 4US FAERS
189Macular fibrosisFAERS: 4US FAERS
190Male Orgasmic DisorderFAERS: 4US FAERS
191Maternal exposure during pregnancyFAERS: 4US FAERS
192Morbid thoughtsFAERS: 4US FAERS
193Multiple sclerosis relapseFAERS: 4US FAERS
194NephrolithiasisFAERS: 4US FAERS
195Obsessive-Compulsive DisorderFAERS: 4US FAERS
196Orthostatic intoleranceFAERS: 4US FAERS
197Otitis MediaFAERS: 4US FAERS
198PancytopeniaFAERS: 4US FAERS
199Product size issueFAERS: 4US FAERS
200Product use in unapproved indicationFAERS: 4US FAERS
201Psychiatric evaluation abnormalFAERS: 4US FAERS
202Psychiatric symptomFAERS: 4US FAERS
203PurpuraFAERS: 4US FAERS
204Restless Legs SyndromeFAERS: 4US FAERS
205SluggishnessFAERS: 4US FAERS
206Supraventricular tachycardiaFAERS: 4US FAERS
207TensionFAERS: 4US FAERS
208Therapeutic response changedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
209Therapy changeFAERS: 4
Canada Vigilance: 6
Canada Vigilance
US FAERS
210Therapy non-responderFAERS: 4US FAERS
211ThirstFAERS: 4US FAERS
212ThrombocytopeniaFAERS: 4US FAERS
213TrismusFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
214Unresponsive to stimuliFAERS: 4US FAERS
215Violence-related symptomFAERS: 4US FAERS
216Wrong technique in product usage processFAERS: 4US FAERS
217Activation syndromeFAERS: 3US FAERS
218Alcohol poisoningFAERS: 3US FAERS
219Altered state of consciousnessFAERS: 3US FAERS
220AnorgasmiaFAERS: 3US FAERS
221Blood follicle stimulating hormone decreasedFAERS: 3US FAERS
222Blood pressure fluctuationFAERS: 3US FAERS
223Brain DeathFAERS: 3US FAERS
224ChokingFAERS: 3US FAERS
225CholestasisFAERS: 3US FAERS
226ClonusFAERS: 3US FAERS
227ColitisFAERS: 3US FAERS
228Conversion disorderFAERS: 3US FAERS
229CyanosisFAERS: 3US FAERS
230DementiaFAERS: 3US FAERS
231DermatitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
232Drug administration errorFAERS: 3US FAERS
233Drug titration errorFAERS: 3US FAERS
234Drug toxicityFAERS: 3US FAERS
235Exposure via breast milkFAERS: 3US FAERS
236Feeding disorder neonatalFAERS: 3US FAERS
237Feeling of body temperature changeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
238FormicationFAERS: 3US FAERS
239Gestational DiabetesFAERS: 3US FAERS
240Gluten sensitivityFAERS: 3US FAERS
241Head discomfortFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
242HostilityFAERS: 3US FAERS
243HypervigilanceFAERS: 3US FAERS
244HypophagiaFAERS: 3US FAERS
245Investigation abnormalFAERS: 3US FAERS
246Irritable Bowel SyndromeFAERS: 3US FAERS
247LacerationFAERS: 3US FAERS
248LaryngospasmFAERS: 3US FAERS
249MaculeFAERS: 3US FAERS
250Male sexual dysfunctionFAERS: 3US FAERS
251MenorrhagiaFAERS: 3US FAERS
252Mental status changesFAERS: 3US FAERS
253Middle insomniaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
254Muscle necrosisFAERS: 3US FAERS
255MyopiaFAERS: 3US FAERS
256Neonatal disorderFAERS: 3US FAERS
257NeuralgiaFAERS: 3US FAERS
258NystagmusFAERS: 3US FAERS
259Orgasmic sensation decreasedFAERS: 3US FAERS
260Pain of skinFAERS: 3US FAERS
261PapuleFAERS: 3US FAERS
262Paradoxical drug reactionFAERS: 3US FAERS
263Partner stressFAERS: 3US FAERS
264Persistent genital arousal disorderFAERS: 3US FAERS
265PetechiaeFAERS: 3US FAERS
266PoisoningFAERS: 3US FAERS
267PolydipsiaFAERS: 3US FAERS
268Product formulation issueFAERS: 3US FAERS
269Rash erythematousFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
270Respiratory FailureFAERS: 3US FAERS
271Respiratory distressFAERS: 3US FAERS
272Shock symptomFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
273SinusitisFAERS: 3US FAERS
274Skin lesionFAERS: 3US FAERS
275StillbirthFAERS: 3US FAERS
276TetanyFAERS: 3US FAERS
277Therapeutic response unexpected with drug substitutionFAERS: 3US FAERS
278Throat irritationFAERS: 3US FAERS
279Tonic clonic movementsFAERS: 3US FAERS
280Transaminases increasedFAERS: 3US FAERS
281Vitreous floatersFAERS: 3US FAERS
282Wrong drug administeredFAERS: 3US FAERS
283Abdominal InfectionFAERS: 2US FAERS
284Accidental exposure to product by childFAERS: 2US FAERS
285Accidental overdoseFAERS: 2US FAERS
286Alanine Aminotransferase IncreasedFAERS: 2US FAERS
287Alopecia AreataFAERS: 2US FAERS
288Amaurosis FugaxFAERS: 2US FAERS
289AngioedemaFAERS: 2US FAERS
290AnhedoniaFAERS: 2US FAERS
291AnosmiaFAERS: 2US FAERS
292AortitisFAERS: 2US FAERS
293ArteriosclerosisFAERS: 2US FAERS
294Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
295AsthenopiaFAERS: 2US FAERS
296Bladder painFAERS: 2US FAERS
297BlindnessFAERS: 2US FAERS
298Blood creatinine increasedFAERS: 2US FAERS
299Blood testosterone decreasedFAERS: 2US FAERS
300Blood urine presentFAERS: 2US FAERS
301Body fat disorderFAERS: 2US FAERS
302BradykinesiaFAERS: 2US FAERS
303Breast discomfortFAERS: 2US FAERS
304BronchitisFAERS: 2US FAERS
305Bulimia NervosaFAERS: 2US FAERS
306Cardiac DeathFAERS: 2US FAERS
307Cerebral InfarctionFAERS: 2US FAERS
308Cerebral disorderFAERS: 2US FAERS
309Cerebral vasoconstrictionFAERS: 2US FAERS
310Choroidal DetachmentFAERS: 2US FAERS
311Complex partial seizuresFAERS: 2US FAERS
312DeafnessFAERS: 2US FAERS
313DehydrationFAERS: 2US FAERS
314DeliriumFAERS: 2US FAERS
315Dental cariesFAERS: 2US FAERS
316DependenceFAERS: 2US FAERS
317Dermatitis acneiformFAERS: 2US FAERS
318Diabetes InsipidusFAERS: 2US FAERS
319Diffuse alopeciaFAERS: 2US FAERS
320DiplopiaFAERS: 2US FAERS
321Drug exposure before pregnancyFAERS: 2US FAERS
322Drug exposure via breast milkFAERS: 2US FAERS
323DysphoniaFAERS: 2US FAERS
324Educational problemFAERS: 2US FAERS
325EnuresisFAERS: 2US FAERS
326Eosinophilic myocarditisFAERS: 2US FAERS
327Epidermal necrosisFAERS: 2US FAERS
328EpidermolysisFAERS: 2US FAERS
329Extra dose administeredFAERS: 2US FAERS
330Eye painFAERS: 2US FAERS
331Facial paralysisFAERS: 2US FAERS
332FlushingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
333Food AllergyFAERS: 2US FAERS
334FumblingFAERS: 2US FAERS
335Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
336GastroschisisFAERS: 2US FAERS
337Hallucinations, mixedFAERS: 2US FAERS
338HemiparesisFAERS: 2US FAERS
339HepatitisFAERS: 2US FAERS
340HungerFAERS: 2US FAERS
341HydrocephalusFAERS: 2US FAERS
342HypogeusiaFAERS: 2US FAERS
343HypokinesiaFAERS: 2US FAERS
344HypomaniaFAERS: 2US FAERS
345Impaired self-careFAERS: 2US FAERS
346Inappropriate schedule of drug administrationFAERS: 2US FAERS
347IncoherentFAERS: 2US FAERS
348Infantile apnoeic attackFAERS: 2US FAERS
349InflammationFAERS: 2US FAERS
350InfluenzaFAERS: 2US FAERS
351Lip swellingFAERS: 2US FAERS
352Low birth weight babyFAERS: 2US FAERS
353Maternal exposure timing unspecifiedFAERS: 2US FAERS
354Micturition frequency decreasedFAERS: 2US FAERS
355Migraine with AuraFAERS: 2US FAERS
356Mouth swellingFAERS: 2US FAERS
357Musculoskeletal discomfortFAERS: 2US FAERS
358Myocardial InfarctionFAERS: 2US FAERS
359NasopharyngitisFAERS: 2US FAERS
360ObesityFAERS: 2US FAERS
361Ocular discomfortFAERS: 2US FAERS
362Panic DisorderFAERS: 2US FAERS
363ParesisFAERS: 2US FAERS
364Performance status decreasedFAERS: 2US FAERS
365Physical assaultFAERS: 2US FAERS
366PleurisyFAERS: 2US FAERS
367PolyhydramniosFAERS: 2US FAERS
368Polymyalgia RheumaticaFAERS: 2US FAERS
369Post-Traumatic Stress DisorderFAERS: 2US FAERS
370Posterior reversible encephalopathy syndromeFAERS: 2US FAERS
371Pregnancy test false positiveFAERS: 2US FAERS
372Premenstrual syndromeFAERS: 2US FAERS
373Pressure of speechFAERS: 2US FAERS
374Product dispensing errorFAERS: 2US FAERS
375Product prescribing errorFAERS: 2US FAERS
376ProteinuriaFAERS: 2US FAERS
377Pulmonary congestionFAERS: 2US FAERS
378PyelocaliectasisFAERS: 2US FAERS
379Rebound effectFAERS: 2US FAERS
380Retinal Vein OcclusionFAERS: 2US FAERS
381Reversible cerebral vasoconstriction syndromeFAERS: 2US FAERS
382Scan adrenal gland abnormalFAERS: 2US FAERS
383ScotomaFAERS: 2US FAERS
384ScreamingFAERS: 2US FAERS
385Sexual inhibitionFAERS: 2US FAERS
386SunburnFAERS: 2US FAERS
387SwellingFAERS: 2US FAERS
388Therapeutic product effect decreasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
389ToothacheFAERS: 2US FAERS
390ToxoplasmosisFAERS: 2US FAERS
391UveitisFAERS: 2US FAERS
392VasculitisFAERS: 2US FAERS
393Vitreous DetachmentFAERS: 2US FAERS
394Vitreous opacitiesFAERS: 2US FAERS
395XerophthalmiaFAERS: 2US FAERS
396AbasiaFAERS: 1US FAERS
397Accidental drug intake by childFAERS: 1US FAERS
398Accidental exposure to productFAERS: 1US FAERS
399AcneFAERS: 1US FAERS
400Acoustic NeuromaFAERS: 1US FAERS
401Acute kidney injuryFAERS: 1US FAERS
402Acute psychosisFAERS: 1US FAERS
403AgoraphobiaFAERS: 1US FAERS
404Allergic reaction to excipientFAERS: 1US FAERS
405Alopecia totalisFAERS: 1US FAERS
406AmaurosisFAERS: 1US FAERS
407Anaphylactic shockFAERS: 1US FAERS
408AneurysmFAERS: 1US FAERS
409Angina PectorisFAERS: 1US FAERS
410Ankle FractureFAERS: 1US FAERS
411Antidepressant drug level above therapeuticFAERS: 1US FAERS
412AphagiaFAERS: 1US FAERS
413Arrhythmogenic Right Ventricular DysplasiaFAERS: 1US FAERS
414ArthropathyFAERS: 1US FAERS
415Artificial rupture of membranesFAERS: 1US FAERS
416AsthmaFAERS: 1US FAERS
417AtaxiaFAERS: 1US FAERS
418Autoimmune hepatitisFAERS: 1US FAERS
419Autoimmune thrombocytopeniaFAERS: 1US FAERS
420AutophobiaFAERS: 1US FAERS
421Bile duct necrosisFAERS: 1US FAERS
422Biopsy liver abnormalFAERS: 1US FAERS
423Bipolar DisorderFAERS: 1US FAERS
424Blood alcohol increasedFAERS: 1US FAERS
425Blood alkaline phosphatase increasedFAERS: 1US FAERS
426Blood amylase increasedFAERS: 1US FAERS
427Blood cholesterol increasedFAERS: 1US FAERS
428Blood glucose fluctuationFAERS: 1US FAERS
429Blood human chorionic gonadotropin decreasedFAERS: 1US FAERS
430Blood insulin decreasedFAERS: 1US FAERS
431Blood lactate dehydrogenase increasedFAERS: 1US FAERS
432Blood pressure inadequately controlledFAERS: 1US FAERS
433Blood sodium increasedFAERS: 1US FAERS
434Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
435Blood triglycerides increasedFAERS: 1US FAERS
436Borderline glaucomaFAERS: 1US FAERS
437Breast FeedingFAERS: 1US FAERS
438Breast MicrocalcificationFAERS: 1US FAERS
439Breast tendernessFAERS: 1US FAERS
440Breech PresentationFAERS: 1US FAERS
441Brief psychotic disorder with marked stressorsFAERS: 1US FAERS
442Cardiac enzymes increasedFAERS: 1US FAERS
443CataractFAERS: 1US FAERS
444Cerebral hypoperfusionFAERS: 1US FAERS
445Cerebral ventricle dilatationFAERS: 1US FAERS
446Choking sensationFAERS: 1US FAERS
447CholecystitisFAERS: 1US FAERS
448ChoroiditisFAERS: 1US FAERS
449ChromaturiaFAERS: 1US FAERS
450Chronic sinusitisFAERS: 1US FAERS
451Congenital HydrocephalusFAERS: 1US FAERS
452Congenital diaphragmatic herniaFAERS: 1US FAERS
453Death of relativeFAERS: 1US FAERS
454Delusional disorder, persecutory typeFAERS: 1US FAERS
455Delusional disorder, unspecified typeFAERS: 1US FAERS
456Depression suicidalFAERS: 1US FAERS
457DextrocardiaFAERS: 1US FAERS
458Dissociative Identity DisorderFAERS: 1US FAERS
459Dissociative disorderFAERS: 1US FAERS
460Distributive shockFAERS: 1US FAERS
461DrowningFAERS: 1US FAERS
462Drug ToleranceFAERS: 1US FAERS
463Drug effect incompleteFAERS: 1US FAERS
464Drug level below therapeuticFAERS: 1US FAERS
465Drug level increasedFAERS: 1US FAERS
466Drug resistanceFAERS: 1US FAERS
467Drug screen positiveFAERS: 1US FAERS
468Dry skinFAERS: 1US FAERS
469Duodenal UlcerFAERS: 1US FAERS
470DysgraphiaFAERS: 1US FAERS
471DysphemiaFAERS: 1US FAERS
472DystoniaFAERS: 1US FAERS
473Ear discomfortFAERS: 1US FAERS
474EclampsiaFAERS: 1US FAERS
475Ectopic PregnancyFAERS: 1US FAERS
476EczemaFAERS: 1US FAERS
477Ejection Fraction DecreasedFAERS: 1US FAERS
478Electrocardiogram QRS complexFAERS: 1US FAERS
479Electrolyte imbalanceFAERS: 1US FAERS
480Elevated moodFAERS: 1US FAERS
481EnteritisFAERS: 1US FAERS
482Enzyme abnormalityFAERS: 1US FAERS
483Erythema InduratumFAERS: 1US FAERS
484ErythromelalgiaFAERS: 1US FAERS
485Essential TremorFAERS: 1US FAERS
486ExcoriationFAERS: 1US FAERS
487ExophthalmosFAERS: 1US FAERS
488Expired product administeredFAERS: 1US FAERS
489Extremity necrosisFAERS: 1US FAERS
490Eye irritationFAERS: 1US FAERS
491Eye operation complicationFAERS: 1US FAERS
492Eyelid irritationFAERS: 1US FAERS
493Failure to ThriveFAERS: 1US FAERS
494Female sexual arousal disorderFAERS: 1US FAERS
495FibromyalgiaFAERS: 1US FAERS
496Flat affectFAERS: 1US FAERS
497Flight of ideasFAERS: 1US FAERS
498FolliculitisFAERS: 1US FAERS
499Frustration tolerance decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
500FrustrationFAERS: 1US FAERS
501GangreneFAERS: 1US FAERS
502GastritisFAERS: 1US FAERS
503Gastrointestinal motility disorderFAERS: 1US FAERS
504Gestational trophoblastic detachmentFAERS: 1US FAERS
505Gingival AtrophyFAERS: 1US FAERS
506GingivitisFAERS: 1US FAERS
507GlossitisFAERS: 1US FAERS
508GoutFAERS: 1US FAERS
509HELLP SyndromeFAERS: 1US FAERS
510Head titubationFAERS: 1US FAERS
511HepatomegalyFAERS: 1US FAERS
512Herbal interactionFAERS: 1US FAERS
513Herpes simplex serology positiveFAERS: 1US FAERS
514Histamine intoleranceFAERS: 1US FAERS
515Histrionic Personality DisorderFAERS: 1US FAERS
516HoloprosencephalyFAERS: 1US FAERS
517Hormone level abnormalFAERS: 1US FAERS
518Hypermobility syndromeFAERS: 1US FAERS
519HyperphagiaFAERS: 1US FAERS
520Hyperplastic cholecystopathyFAERS: 1US FAERS
521HyperpyrexiaFAERS: 1US FAERS
522Hypertensive crisisFAERS: 1US FAERS
523HyperthyroidismFAERS: 1US FAERS
524HypertrophyFAERS: 1US FAERS
525HyperventilationFAERS: 1US FAERS
526HypophysitisFAERS: 1US FAERS
527Hypoplastic Left Heart SyndromeFAERS: 1US FAERS
528HyporeflexiaFAERS: 1US FAERS
529HypoxiaFAERS: 1US FAERS
530ImpatienceFAERS: 1US FAERS
531Incorrect drug administration durationFAERS: 1US FAERS
532Incorrect drug administration rateFAERS: 1US FAERS
533Intentional product use issueFAERS: 1US FAERS
534Intercepted medication errorFAERS: 1US FAERS
535Iron deficiencyFAERS: 1US FAERS
536Joint destructionFAERS: 1US FAERS
537Joint injuryFAERS: 1US FAERS
538Joint swellingFAERS: 1US FAERS
539Keratoconjunctivitis SiccaFAERS: 1US FAERS
540KetoacidosisFAERS: 1US FAERS
541Lactose IntoleranceFAERS: 1US FAERS
542Large intestine perforationFAERS: 1US FAERS
543Left ventricle outflow tract obstructionFAERS: 1US FAERS
544LeukoencephalopathyFAERS: 1US FAERS
545Limb discomfortFAERS: 1US FAERS
546Lipoprotein (a) increasedFAERS: 1US FAERS
547Long QT SyndromeFAERS: 1US FAERS
548Loss of bladder sensationFAERS: 1US FAERS
549Loss of proprioceptionFAERS: 1US FAERS
550Lower respiratory tract infectionFAERS: 1US FAERS
551LymphocytosisFAERS: 1US FAERS
552MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
553Mastication disorderFAERS: 1US FAERS
554MastitisFAERS: 1US FAERS
555MicrocephalyFAERS: 1US FAERS
556MicrophthalmosFAERS: 1US FAERS
557MonoplegiaFAERS: 1US FAERS
558Multiple allergiesFAERS: 1US FAERS
559Multiple drug overdoseFAERS: 1US FAERS
560Muscle SpasticityFAERS: 1US FAERS
561Muscle tightnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
562MutismFAERS: 1US FAERS
563MyocarditisFAERS: 1US FAERS
564Myoclonic EpilepsyFAERS: 1US FAERS
565MyopathyFAERS: 1US FAERS
566NarcolepsyFAERS: 1US FAERS
567Neonatal aspirationFAERS: 1US FAERS
568Nerve injuryFAERS: 1US FAERS
569Neurological decompensationFAERS: 1US FAERS
570Nuchal RigidityFAERS: 1US FAERS
571Oculogyric crisisFAERS: 1US FAERS
572OligospermiaFAERS: 1US FAERS
573Optic AtrophyFAERS: 1US FAERS
574Oral mucosal eruptionFAERS: 1US FAERS
575Oropharyngeal blisteringFAERS: 1US FAERS
576Oropharyngeal discomfortFAERS: 1US FAERS
577Oropharyngeal painFAERS: 1US FAERS
578Oropharyngeal plaqueFAERS: 1US FAERS
579Oropharyngeal spasmFAERS: 1US FAERS
580Oropharyngeal swellingFAERS: 1US FAERS
581PallorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
582Palpable purpuraFAERS: 1US FAERS
583Pancreatic InsufficiencyFAERS: 1US FAERS
584PancreatitisFAERS: 1US FAERS
585Patent ductus arteriosusFAERS: 1US FAERS
586Pelvic kidneyFAERS: 1US FAERS
587Pericardial effusionFAERS: 1US FAERS
588Periorbital contusionFAERS: 1US FAERS
589Peripheral swellingFAERS: 1US FAERS
590PeritonitisFAERS: 1US FAERS
591Physical examination abnormalFAERS: 1US FAERS
592Pleuritic painFAERS: 1US FAERS
593Pregnancy on contraceptiveFAERS: 1US FAERS
594Pregnancy with contraceptive deviceFAERS: 1US FAERS
595Premature EjaculationFAERS: 1US FAERS
596Prescribed underdoseFAERS: 1US FAERS
597ProctitisFAERS: 1US FAERS
598Product contamination physicalFAERS: 1US FAERS
599Product friableFAERS: 1US FAERS
600Product label confusionFAERS: 1US FAERS
601Product label on wrong productFAERS: 1US FAERS
602Product measured potency issueFAERS: 1US FAERS
603Product packaging issueFAERS: 1US FAERS
604Product physical issueFAERS: 1US FAERS
605ProstatectomyFAERS: 1US FAERS
606Psychiatric decompensationFAERS: 1US FAERS
607Psychomotor AgitationFAERS: 1US FAERS
608Psychomotor skills impairedFAERS: 1US FAERS
609Pulmonary EmbolismFAERS: 1US FAERS
610Pulmonary HypertensionFAERS: 1US FAERS
611RadiculopathyFAERS: 1US FAERS
612Renal cystFAERS: 1US FAERS
613Renal dysplasiaFAERS: 1US FAERS
614Respiratory DepressionFAERS: 1US FAERS
615Respiratory arrestFAERS: 1US FAERS
616Retinal DetachmentFAERS: 1US FAERS
617Rheumatoid ArthritisFAERS: 1US FAERS
618RhinitisFAERS: 1US FAERS
619Rubella antibody positiveFAERS: 1US FAERS
620SchizophreniaFAERS: 1US FAERS
621Sense of oppressionFAERS: 1US FAERS
622SepsisFAERS: 1US FAERS
623Septic ShockFAERS: 1US FAERS
624ShockFAERS: 1US FAERS
625Simple Partial SeizuresFAERS: 1US FAERS
626Sinus ArrhythmiaFAERS: 1US FAERS
627Sinus TachycardiaFAERS: 1US FAERS
628Skin PapillomaFAERS: 1US FAERS
629Skin toxicityFAERS: 1US FAERS
630Sleep TalkingFAERS: 1US FAERS
631Slow response to stimuliFAERS: 1US FAERS
632Slow speechFAERS: 1US FAERS
633SneezingFAERS: 1US FAERS
634SnoringFAERS: 1US FAERS
635Solar dermatitisFAERS: 1US FAERS
636Sperm count decreasedFAERS: 1US FAERS
637Spousal AbuseFAERS: 1US FAERS
638Squamous cell carcinomaFAERS: 1US FAERS
639StaringFAERS: 1US FAERS
640Synovial CystFAERS: 1US FAERS
641Temperature intoleranceFAERS: 1US FAERS
642Tension HeadacheFAERS: 1US FAERS
643Therapeutic product effect incompleteFAERS: 1US FAERS
644Therapeutic product ineffectiveFAERS: 1US FAERS
645Thermal burnFAERS: 1US FAERS
646Tongue discomfortFAERS: 1US FAERS
647Tongue spasmFAERS: 1US FAERS
648Trisomy 21FAERS: 1US FAERS
649Upper motor neurone lesionFAERS: 1US FAERS
650Urinary IncontinenceFAERS: 1US FAERS
651Urinary hesitationFAERS: 1US FAERS
652Urinary tract infectionFAERS: 1US FAERS
653Urine flow decreasedFAERS: 1US FAERS
654Vaginal PerforationFAERS: 1US FAERS
655Vascular ruptureFAERS: 1US FAERS
656Ventricular arrhythmiaFAERS: 1US FAERS
657Ventricular hypokinesiaFAERS: 1US FAERS
658Vibratory sense increasedFAERS: 1US FAERS
659Victim of spousal abuseFAERS: 1US FAERS
660Vocal Cord ParalysisFAERS: 1US FAERS
661Vulvovaginal burning sensationFAERS: 1US FAERS
662Vulvovaginal drynessFAERS: 1US FAERS
663White blood cell count decreasedFAERS: 1US FAERS
664Wrong technique in drug usage processFAERS: 1US FAERS
665Erection increasedCanada Vigilance: 1Canada Vigilance
666Flank PainCanada Vigilance: 1Canada Vigilance
667Product dose omissionCanada Vigilance: 1Canada Vigilance
668Product used for unknown indicationCanada Vigilance: 1Canada Vigilance
669Saliva alteredCanada Vigilance: 1Canada Vigilance
670Swelling of eyelidCanada Vigilance: 1Canada Vigilance
671skin abrasionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.